Teratogenic potency of valproate analogues evaluated by quantitative estimation of cellular morphology in vitro.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Toxicology in Vitro

• Publication date

  1996-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0887-2333(96)00049-5PMID 20650240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ciba Foundation Symposium

  1997cited by this paper
• Validation of an in vitro teratology system using chiral substances: stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos.

  1995cited by this paper
• Localization of NCAM on NCAM‐B‐expressing cells with inhibited migration in collagen

  1995cited by this paper
• Valproic acid-induced neural tube defects.

  1994cited by this paper
• Evaluation of the rat embryo culture system as a predictive test for human teratogens.

  1994cited by this paper
• The teratogenic effects of valproic acid in human chondrogenesis in vitro.

  1994cited by this paper
• The structural bases of integrin-ligand interactions.

  1994cited by this paper
• Trans-2-ene-valproic acid is less behaviorally teratogenic than an equivalent dose of valproic acid in rats.

  1994cited by this paper
• The effect of cell confluency state on the expression of neural cell surface glycoconjugates.

  1994cited by this paper
• In vitro tests for teratogens: desirable endpoints, test batteries and current status of the micromass teratogen test.

  1993cited by this paper
• Analysis of multi-parameter video measurements of human neutrophil movement and its relation to cell shape and cytosolic calcium.

  1993cited by this paper
• Migratory, invasive and metastatic capacity of NCAM transfected rat glioma cells

  1993cited by this paper
• The valproic acid metabolite E-2-n-propyl-2-pentenoic acid does not induce spina bifida in the mouse.

  1992cited by this paper
• Valproic acid-induced spina bifida: a mouse model.

  1992cited by this paper
• Analysis of high dysmorphogenic activity of Ro 13-6307, a tetramethylated tetralin analog of retinoic acid.

  1992cited by this paper
• The Enantiomers of the Valproic Acid Analogue 2-n-Propyl-4-pentynoic Acid (4-yn-VPA): Asymmetric Synthesis and Highly Stereoselective Teratogenicity in Mice

  1992cited by this paper
• Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.

  1991cited by this paper
• The anticonvulsant valproate teratogen restricts the glial cell cycle at a defined point in the mid-G1 phase.

  1991cited by this paper
• Computer automation in measurement and analysis of cell motility in vitro.

  1991cited by this paper
• Cell Motility Factors

  1991cited by this paper
• In vitro screening for anticonvulsant‐induced teratogenesis: Drug alteration of cell adhesivity

  1991cited by this paper
• Deposition of extracellular matrix along the pathways of migrating fibroblasts

  1990cited by this paper
• In vitro screening for anticonvulsant‐induced teratogenesis in neural primary cultures and cell lines

  1990cited by this paper
• Binding Properties of the Neural Cell Adhesion Molecule to Different Components of the Extracellular Matrix

  1989cited by this paper
• Equilibrium Binding Analysis of Neural Cell Adhesion Molecule Binding to Heparin

  1989cited by this paper
• The anticonvulsant sodium valproate specifically induces the expression of a rat glial heat shock protein which is identified as the collagen type IV receptor.

  1988cited by this paper
• “Dynamic morphology system”: A method for quantitating changes in shape, pseudopod formation, and motion in normal and mutant amoebae of Dictyostelium discoideum

  1988cited by this paper
• Asymmetric glycine enolate aldol reactions: synthesis of cyclosporin's unusual amino acid, MeBmt

  1986cited by this paper
• Species differences in pharmacokinetics and drug teratogenesis.

  1986cited by this paper
• Therapeutic levels of sodium valproate inhibit mitotic indices in cells of neural origin.

  1985cited by this paper
• Teratogenicity of valproic acid: In vivo and in vitro investigations

  1981cited by this paper
• Phenotypic properties of neoplastic cell lines developed from fetal rat brain cells in culture after exposure to ethylnitrosourea in vivo

  1977cited by this paper
• Natural acetylenes. Part XLIII. Polyacetylenes from cultures of the fungus Fistulina pallida(berk. and rev.)

  1974cited by this paper
• Book Review: Treatise on Collagen

  1969cited by this paper
• Der Nachbargruppeneffekt bei Additionsreaktionen VI. Mitt.: Lactonisierung von Penten‐(4)‐säuren durch Jod

  1965cited by this paper

• The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities.

  2011cites this paper
• Neural Tube Defect-causing Teratogens Affect Tissue Mechanical Properties and Cytoskeletal Morphology in Axolotl Embryos

  2007cites this paper
• Valproate activates phosphodiesterase-mediated cAMP degradation: relevance to C6 glioma G1 phase progression.

  2004cites this paper
• Discriminative power of an assay for automated in vitro screening of teratogens.

  2004cites this paper
• Differential enantioselective effects of pentyl‐4‐yn‐valproate on spatial learning in the rat, and neurite outgrowth and cyclin D3 expression in vitro

  2003cites this paper
• Experimentelle Studien zur Teratogenität von Valproinsäure

  2002cites this paper
• Automated in vitro screening of teratogens.

  2002cites this paper
• Neural crest cell motility in valproic acid.

  2002cites this paper
• Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase

  2002cites this paper
• The effect of valproic acid on motility and morphometry parameters, and actin and N-cadherin distribution in avian neural crest cells

  2001cites this paper
• Antiproliferative actions of inhalational anesthetics: comparisons to the valproate teratogen

  2000cites this paper
• Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeleton.

  1999cites this paper
• New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).

  1999cites this paper
• The HPV-16 E5 oncogene and bafilomycin A(1) influence cell motility.

  1999cites this paper
• Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre.

  1998cites this paper
• Radial astrocytes: toxic effects induced by antiepileptic drug in the developing rat hippocampus in vitro.

  1998cites this paper
• Cell proliferation, migration and CAM-dependent neurite outgrowth as developmental in vitro endpoints for screening teratogenic potential: Application to valproic acid and related analogues of varying potency.

  1998cites this paper
• Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues.

  1998cites this paper
• Protein kinase C inhibitors arrest the C6 glioma cell cycle at a mid-G1 phase restriction point: Implications for the antiproliferative action of valproate.

  1997cites this paper
• Valproic acid suppresses G1 phase‐dependent sialylation of a 65 kDa glycoprotein in the C6glioma cell cycle

  1997cites this paper